National consensus on management patients with endometriosis

Authors

  • В. М. Запорожан Odessa National Medical University, Ukraine
  • Т. Ф. Татарчук Institute of Pediatrics, Obstetrics and Gynecology of the NAM S of Ukraine, Ukraine
  • В. В. Камінський Postgraduate Education named after P.L. Shupyk; Kiev City Center of Reproductive and Perinatal Medicine, Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2015.24.7-12

Keywords:

consensus, endometriosis, endometrial heterotopia, estrogens

Abstract

The National consensus on management patients with endometriosis includes the main issues of epidemiology, clinical manifestations, and diagnostics of this disease. The document also contained evidence-based recommendations on treatment tactics of endometriosis (medical and surgical treatment), secondary prevention of endometriosis.

Author Biographies

В. М. Запорожан, Odessa National Medical University

Moderator, MD, Professor, Academician of Academy of Medical Sciences of Ukraine, Rector, Head of the Obstetrics and Gynaecology Department № 1

Т. Ф. Татарчук, Institute of Pediatrics, Obstetrics and Gynecology of the NAM S of Ukraine

Moderator, MD, professor, corresponding member of the NAM S of Ukraine, Deputy Director for Research Work, Chief of the Endocrine Gynecology Department

В. В. Камінський, Postgraduate Education named after P.L. Shupyk; Kiev City Center of Reproductive and Perinatal Medicine

Moderator, MD, professor, corresponding member of the NAM S of Ukraine, head of the Obstetrics, Gynecology and Reproductology Department of the National Medical Academy;

chief specialist in Obstetrics and Gynecology at the Ministry of Health of Ukraine, directof 

References

  1. SOGC Clinical practice guideline: diagnosis and management of endometriosis. JOGC, 2010.
  2. Sinaii, N., et al. “Differences in characteristics among 1.000 women with endometriosis based on extent of disease.” Fertil Steril, 89(3) (2008): 538–545.
  3. Guideline of the European Society of Human Reproduction and Embryology. Management of endometriosis, 2013.
  4. M ol, B.W., Bayram, N., Lijmer, J.G., Wiegerinck, M.A., et al. “The performance of CA -125 measurement in the detection of endometriosis: a meta-analysis.” Fertil Steril, 70(1998): 1101–1108.
  5. C onsensus on current management of endometriosis. Hum Reprod, 28(6) (2013): 1552–1568.
  6. M ueck, A.O. “Dienogest: an oral progestogen for the treatment of endometriosis.” Expert Review of Obstetrics & Gynecology, 1 (Vol. 6) (2011): 5–15.
  7. Köhler, G., Faustmann, T.A., Gerlinger, C., Seitz, C., Mueck, A.O. “A dose-ranging study to determine the efficacy and safety of 1, 2 and 4 mg of dienogest daily for endometriosis.” Int J Gynecol Obstet, 108(2010): 21–25.
  8. Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., Seitz, C. “Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.” Hum Reprod, 25(2010): 633–634.
  9. Harada, T., Momoeda, M., Taketani, Y., Aso, T., et al. “Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial.” Fertil Steril, 91(3) (2009): 675–681.
  10. C osson, M., Querleu, D., Donnez, J., Madelenat, P., et al. “Dienogest is as effective astriptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.” Fertil Steril, 77(2002): 684–692.
  11. Schindler, A.E. “Dienogest in long-term treatment of endometriosis.” Int J Womens Health, 3(2011): 175–184.
  12. Schlaff, W.D., Carson, S.A., Luciano, A., Ross, D., Bergqvist, A. “Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.” Fertil Steril, 85(2006): 314–325.
  13. C rosignani, P.G., Luciano, A., Ray, A., Bergqvist, A. “Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.” Hum Reprod, 21(2006): 248–256.
  14. P etta, C.A., Ferriani, R.A., Abrao, M.S., Hassan, D., et al. “Randomized clinical trial of a levonorgestrel -releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.” Hum Reprod, 20(2005): 1993.
  15. Vercellini, P., Aimi, G., Panazza, S., et al. “A levonorgestrel – releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study.” Fertil Steril, 72(1999): 505–508.
  16. Fedele, L., Bianchi, S., Zanconato, G., Portuese, A., Raffaelli, R. “Use of a levonorgestrel -releasing intrauterine device in the treatment of rectovaginal endometriosis.” Fertil Steril, 75(2001): 485–488.
  17. W ong, C., et al. “Oral contraceptive pill as treatment for primary dysmenorrhoea.” Cochrane Database Syst Rev (2009).
  18. Yap, C. “Pre and post operative medical therapy for endometriosis surgery.” Cochrane Database Syst Rev, 3(2004): CD003678.

Published

2015-12-01

How to Cite

Запорожан, В. М., Татарчук, Т. Ф., & Камінський, В. В. (2015). National consensus on management patients with endometriosis. REPRODUCTIVE ENDOCRINOLOGY, (24), 7–12. https://doi.org/10.18370/2309-4117.2015.24.7-12

Issue

Section

Health care

Most read articles by the same author(s)

1 2 3 4 5 6 > >>